Abbott: A Promise for Life
Menu Search

 

Abbott - A Promise for Life
  • Home
  • About Abbott
  • Products
  • Global Citizenship
  • Careers
  • Newsroom
    • Press Releases
    • Feature Stories
    • Conferences & Events
    • Fact Sheets
    • Media Contacts & News Sites
    • Leadership Team
    • Rankings & Honors
    • Follow Us
    • Media Library
    • Set Up E-mail Alerts
    • Press Kit - Separation
  • Investor Relations
  • Partnerships
Abbott — A Promise for Life
  • Select a Country
  • Site Map
  • Contact Us

Press Releases

You Narrowed By: 2010

Showing 1-3 of 3

First 1 Last

Narrow your search by using keywords.

2010

September

September 23

Abbott's XIENCE V® Shows Outstanding Two-Year Clinical Results Versus TAXUS® in Key Safety and Efficacy Measures in SPIRIT IV Trial
 

May

May 25

Abbott's Investigational MitraClip® System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
 

March

March 14

New Data Demonstrates Abbott's Investigational MitraClip® System Has Potential to be a Valuable Treatment Option for Patients with Mitral Regurgitation, the Most Common Heart Valve Condition
First 1 Last

Narrow by Year

  • 2013 (26 items)
  • 2012 (105 items)
  • 2011 (115 items)
  • 2010 (3 items)
  • 2009 (3 items)

Narrow to Show

  • Business/Product Release (174 items)
  • Citizenship Release (15 items)
  • Financial Release (47 items)
  • Recognition Release (14 items)
  • Scientific Release (13 items)

For a different perspective on Abbott News. . .

  • View Abbott Feature Stories
  • Home
  • Select a Country
  • Site Map
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Full Site
Follow @AbbottNews

© 2006, 2013 Abbott Laboratories, Abbott Park, Illinois, USA

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.